OrbiMed’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-2,207,245
| Closed | -$2.94M | – | 142 |
|
2017
Q3 | $2.94M | Sell |
2,207,245
-1,043,055
| -32% | -$1.39M | 0.03% | 123 |
|
2017
Q2 | $5.1M | Hold |
3,250,300
| – | – | 0.05% | 109 |
|
2017
Q1 | $10.5M | Hold |
3,250,300
| – | – | 0.12% | 95 |
|
2016
Q4 | $4.39M | Hold |
3,250,300
| – | – | 0.06% | 109 |
|
2016
Q3 | $5.07M | Hold |
3,250,300
| – | – | 0.06% | 112 |
|
2016
Q2 | $4.32M | Sell |
3,250,300
-473,228
| -13% | -$629K | 0.05% | 108 |
|
2016
Q1 | $19.6M | Sell |
3,723,528
-692,772
| -16% | -$3.65M | 0.21% | 65 |
|
2015
Q4 | $34.7M | Hold |
4,416,300
| – | – | 0.31% | 60 |
|
2015
Q3 | $37.3M | Hold |
4,416,300
| – | – | 0.38% | 54 |
|
2015
Q2 | $48.4M | Buy |
4,416,300
+151,400
| +4% | +$1.66M | 0.4% | 54 |
|
2015
Q1 | $59.6M | Sell |
4,264,900
-472,000
| -10% | -$6.6M | 0.51% | 53 |
|
2014
Q4 | $80M | Hold |
4,736,900
| – | – | 0.76% | 37 |
|
2014
Q3 | $63.6M | Hold |
4,736,900
| – | – | 0.66% | 40 |
|
2014
Q2 | $60.3M | Hold |
4,736,900
| – | – | 0.71% | 40 |
|
2014
Q1 | $56.3M | Sell |
4,736,900
-57,400
| -1% | -$682K | 0.69% | 41 |
|
2013
Q4 | $66.2M | Buy |
4,794,300
+201,700
| +4% | +$2.79M | 0.97% | 33 |
|
2013
Q3 | $80M | Buy |
4,592,600
+71,800
| +2% | +$1.25M | 1.43% | 24 |
|
2013
Q2 | $73.2M | Buy |
+4,520,800
| New | +$73.2M | 1.55% | 25 |
|